Moltic Pharma is a drug discovery company developing ion channel modulators for neurological diseases, focusing on epilepsy. Our modulators are small molecule compounds that open a voltage-gated potassium channel, the Kv7.2/7.3 channel, via a unique binding site and mechanism of action. To open this ion channel is a clinically validated strategy to prevent epileptic seizures.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Moltic Pharma Questions
Moltic Pharma's LinkedIn profile is https://www.linkedin.com/company/moltic-pharma
Moltic Pharma has
1 employees.
View email and phone details for 1
employees at Moltic Pharma.
Moltic Pharma's industry is
Research Services
Moltic Pharma's top competitors are
Aax Biotech Ab,
Molecular Attraction Ab,
3n Bio,
Medos Ab,
Analecto,
Neobiomics,
Sequrna,
Zerocyte Medical Ab,
Voxlbio,
Basic Genomics Ab.
Moltic Pharma's categories are Research Services
Moltic Pharma's founding year is 2017
